PERSPECTIVE THERAPEUTICS, INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
PERSPECTIVE THERAPEUTICS, INC. (CATX) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of $1.51 million for the 12-month period ending 2017-06-30, per its 10-K filed 2017-09-28.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-09-28
- PERSPECTIVE THERAPEUTICS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was $2.04M, a 63.82% decline year-over-year.
- PERSPECTIVE THERAPEUTICS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was -$83.00K, a 101.44% decline year-over-year.
- PERSPECTIVE THERAPEUTICS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was -$121.00K.
- PERSPECTIVE THERAPEUTICS, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-09-30 was -$327.00K.
- PERSPECTIVE THERAPEUTICS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2017 was $1.51M, a 82.71% decline from fiscal 2016.
- PERSPECTIVE THERAPEUTICS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was $8.76M, a 1016.96% increase from fiscal 2015.
- PERSPECTIVE THERAPEUTICS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was $784.00K.
- PERSPECTIVE THERAPEUTICS, INC. net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$15.44M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2017-06-30 | $2.04M derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-28 | $1.96M derived: sum of 2 quarters · filed 2017-09-28 | $1.84M derived: sum of 3 quarters · filed 2017-09-28 | $1.51M 10-K · filed 2017-09-28 | ||||
| 2017-03-31 | -$83.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-10 | -$204.00K derived: sum of 2 quarters · filed 2017-05-10 | -$531.00K 10-Q · filed 2017-05-10 | $5.12M derived: sum of 4 quarters · filed 2017-09-28 | ||||
| 2016-12-31 | -$121.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-09 | -$448.00K 10-Q · filed 2017-02-09 | $5.21M derived: sum of 3 quarters · filed 2017-09-28 | $10.97M derived: sum of 4 quarters · filed 2017-09-28 | ||||
| 2016-09-30 | -$327.00K 10-Q · filed 2016-11-09 | $5.33M derived: sum of 2 quarters · filed 2017-09-28 | $11.09M derived: sum of 3 quarters · filed 2017-09-28 | $11.01M derived: sum of 4 quarters · filed 2017-09-28 | ||||
| 2016-06-30 | $5.65M derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-28 | $11.42M derived: sum of 2 quarters · filed 2017-09-28 | $11.33M derived: sum of 3 quarters · filed 2017-09-28 | $8.76M 10-K · filed 2017-09-28 | $8.76M 10-K · filed 2016-09-09 | |||
| 2016-03-31 | $5.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-10 | $5.68M derived: sum of 2 quarters · filed 2017-05-10 | $3.10M 10-Q · filed 2017-05-10 | $3.10M 10-Q · filed 2016-05-10 | $7.80M derived: sum of 4 quarters · filed 2017-09-28 | |||
| 2015-12-31 | -$87.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-09 | -$2.66M 10-Q · filed 2017-02-09 | -$2.66M 10-Q · filed 2016-02-09 | $2.04M derived: sum of 3 quarters · filed 2017-09-28 | $2.91M derived: sum of 4 quarters · filed 2017-09-28 | |||
| 2015-09-30 | -$2.58M 10-Q · filed 2016-11-09 | -$2.58M 10-Q · filed 2015-11-09 | $2.12M derived: sum of 2 quarters · filed 2017-09-28 | $3.00M derived: sum of 3 quarters · filed 2017-09-28 | $2.88M derived: sum of 4 quarters · filed 2017-09-28 | |||
| 2015-06-30 | $4.70M derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-28 | $5.57M derived: sum of 2 quarters · filed 2017-09-28 | $5.46M derived: sum of 3 quarters · filed 2017-09-28 | $784.00K 10-K · filed 2017-09-28 | $783.66K 10-K · filed 2015-09-14 | |||
| 2015-03-31 | $875.13K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-10 | $761.74K derived: sum of 2 quarters · filed 2016-05-10 | -$3.92M 10-Q · filed 2016-05-10 | -$19.34M derived: sum of 4 quarters · filed 2016-09-09 | ||||
| 2014-12-31 | -$113.39K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-09 | -$4.79M 10-Q · filed 2016-02-09 | -$20.21M derived: sum of 3 quarters · filed 2016-09-09 | -$20.22M derived: sum of 4 quarters · filed 2016-09-09 | ||||
| 2014-09-30 | -$4.68M 10-Q · filed 2015-11-09 | -$20.10M derived: sum of 2 quarters · filed 2016-09-09 | -$20.10M derived: sum of 3 quarters · filed 2016-09-09 | -$20.11M derived: sum of 4 quarters · filed 2016-09-09 | ||||
| 2014-06-30 | -$15.42M derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-09 | -$15.43M derived: sum of 2 quarters · filed 2016-09-09 | -$15.44M derived: sum of 3 quarters · filed 2016-09-09 | -$15.44M 10-K · filed 2016-09-09 | ||||
| 2014-03-31 | -$5.53K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-15 | -$16.91K derived: sum of 2 quarters · filed 2015-05-15 | -$21.55K 10-Q · filed 2015-05-15 | -$21.33K derived: sum of 4 quarters · filed 2015-09-14 | ||||
| 2013-12-31 | -$11.38K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-17 | -$16.01K 10-Q · filed 2015-02-17 | -$15.80K derived: sum of 3 quarters · filed 2015-09-14 | -$15.34K derived: sum of 4 quarters · filed 2015-09-14 | ||||
| 2013-09-30 | -$4.63K 10-Q · filed 2014-11-14 | -$4.42K derived: sum of 2 quarters · filed 2015-09-14 | -$3.96K derived: sum of 3 quarters · filed 2015-09-14 | |||||
| 2013-06-30 | $214.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-14 | $675.00 derived: sum of 2 quarters · filed 2015-09-14 | -$12.82K 10-K · filed 2015-09-14 | |||||
| 2013-03-31 | $461.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-05-15 | -$13.03K 10-Q · filed 2014-05-15 | ||||||
| 2012-12-31 | -$13.49K 10-Q · filed 2014-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |